25 years' experience in venture capital and private equity with a primary focus on life science investment
Mr. Yang is the Founding Partner and CEO of Blue Ocean Capital Group ("BOCG”). He has 25 years’ experience in venture capital and private equity with a primary focus on life science investment and more than US$ 1 billion proven track records. He led a symbolic US$ 250 million cross-border healthcare M&A which won him distinguished awards including “the Top Healthdcare 10 Private Equity Investments” and “the Best M&A Financing Award” of the year. Recent investments led by Mr. Yang including Hightide Therapeutics, Ribo Life Science, Boan Biotech, INNORNA and CureGenetics.
Before Mr. Yang founded BOCG, he served as the managing director of China Construction Bank International (“CCBI”), in charge of healthcare investment with dual currency funds. Prior to that, as head and managing director of PPF Group, a leading financial institution in Central and Eastern Europe, Mr. Yang was responsible for strategic investment in Asia and contributed to the establishment of HomeCredit China. He also used to work at the Growth Fund of Texas Pacific Group (TPG) in the summer of 2007. Mr. Yang’s investment career started in 2001 when he served as a founding member and vice president of the venture capital arm of Xiangcai Securities, where he succeeded in raising fund and achieving 6X return on investment.
Mr. Yang sits on the boards of various influential industrial organizations including HK Bio-Med Innovation Association (“HKBMIA”), Chinese Financial Association in Hong Kong(“HCFA”), Greatr China Committee of Hong Kong Venture Capital and Private Equity Association (“HKVCA”), and the advisory board of HKUST Business School. Mr. Yang Feng is committed to supporting the innovation and funding startups of life science across regions. With Mr. Yang’s initial, BOCG became a signatory party to the United Nations-supported Principles for Responsible Investment ("UN PRI"), promoting ESG and sustainable development. Mr. Yang is enthusiastic of contemporary art and has sponsored enormous art exhibitions and publishing internationally, and was a patron of UCCA and sat on the First New Art Council of M+ Museum in Hong Kong.
Mr. Yang holds the MBA degree from HKUST with exchange experience in Columbia University in New York and HHL Business School in Leipzig. He was also accepted by Harvard Medical School for the Global Healthcare Leaders Program (GHLP) since 2024.